博济医药：有望获得更多新药研发项目与订单

Group 1 - The core viewpoint is that innovative drug commercial insurance is expected to alleviate the medication burden on patients and open new market channels for pharmaceutical companies, thereby enhancing confidence in R&D for innovative drugs within the industry [1] - The company, as a specialized CRO service provider, is likely to gain more new drug R&D projects and orders [1]